Following the authorization of the coronavirus vaccine developed by the British-Swedish company Astrazeneca, concerning reports emerged. The vaccine, known as “Vaxzevria,” was associated with severe side effects in extremely rare instances. Some individuals vaccinated experienced thrombosis in the brain or abdominal organs, resulting in fatalities. Initially believed to predominantly affect young women, the vaccine was initially advised only for individuals over 60 in Germany and later not recommended at all.

Questions arose regarding what Astrazeneca knew about these occurrences and whether they could have been prevented. A woman from Upper Franconia, who suffered from thrombosis in the intestine and fell into a coma after receiving the Astrazeneca vaccine in March 2021, demanded not only compensation from the pharmaceutical company but also the disclosure of documents from the clinical trials.

A partial victory was achieved by the woman before the Bamberg Higher Regional Court. On Monday, a civil chamber ruled that the company must provide comprehensive information regarding all known effects and side effects of its coronavirus vaccine, specifically those relevant to the plaintiff’s clinical condition. This encompassed any additional findings gathered between the vaccine’s approval in December 2020 and February 2024.